Drug intelligence / Profile preview

acetylsalicylic acid + calcium carbonate

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Acetylsalicylic acid + calcium carbonate is a fixed-dose combination of two active ingredients. Acetylsalicylic acid (commonly known as aspirin) is a non-selective cyclooxygenase (COX) inhibitor that provides analgesic, antipyretic, anti-inflammatory effects and irreversibly inhibits platelet aggregation by blocking COX-1 and COX-2 enzymes. This action reduces the synthesis of prostaglandins and thromboxane A2, leading to pain relief and prevention of blood clots[3][4]. Calcium carbonate acts as an antacid by neutralizing gastric hydrochloric acid and increasing gastric pH; it also serves as a dietary calcium supplement[5][7]. The combination is used for the treatment of mild to moderate pain, fever, inflammatory conditions such as arthritis, prevention of heart attack or stroke due to its antiplatelet effect (from aspirin), while the addition of calcium carbonate helps reduce gastrointestinal irritation caused by aspirin[1][2].

Brand names
MagnaprinAspirin BufferedArthritis Pain FormulaAspir-Mox
Other names
aspirin + calcium carbonate
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on acetylsalicylic acid + calcium carbonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetylsalicylic acid + calcium carbonate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call